Promoting the reform of the review and approval system of traditional Chinese medicine is an important measure to implement the opinions of the CPC Central Committee and the State Council on promoting the inheritance, innovation and development of traditional Chinese medicine. In order to further build and improve the evaluation and approval system in line with the characteristics of traditional Chinese medicine, ensure and promote the scientificity and authority of major decisions in the supervision of traditional Chinese medicine, according to the relevant provisions of the measures for the administration of drug registration, the State Food and Drug Administration decided to establish an expert advisory committee for strategic decision-making in the management of traditional Chinese medicine (hereinafter referred to as the”special committee”) composed of academicians of the Chinese Academy of Sciences and the Chinese Academy of Sciences, masters of traditional Chinese medicine, and senior experts. The chairman of the special committee is sunxianze, and the vice chairmen are Zhang Boli, Huang Luqi and Wang Chen. The Secretariat is located in the drug registration administration department of the State Food and drug administration. The list of the special committee is now published. The term of office of the chairman, vice chairmen and members is 3 years.
List of members of the Expert Advisory Committee on strategic decision-making in the management of traditional Chinese Medicine
1、 Academician of the Chinese Academy of Sciences
2、 Academician of the Chinese Academy of Engineering
3、 Master of Chinese Medicine
4、 Senior experts